WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Stepped Care for Depression in Heart Failure

Not Applicable

Completed

Conditions: Heart Failure
Depressive Disorder, Major

Interventions: Behavioral: Stepped care for depression

First Posted Date: 2016-12-20

Last Posted Date: 2023-02-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 139

Registration Number: NCT02997865

Locations: 🇺🇸
Behavioral Medicine Center Washington University, Saint Louis, Missouri, United States

CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndromes
MDS
AML

Interventions: Drug: CX-01
Drug: Azacitidine
Procedure: Bone marrow biopsy
Procedure: Peripheral blood draw

First Posted Date: 2016-12-16

Last Posted Date: 2019-12-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT02995655

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

Phase 1

Terminated

Conditions: Depressive Disorder, Major
Depressive Disorder, Treatment-Resistant

Interventions: Drug: Placebo gas
Drug: Nitrous Oxide
Device: MRI

First Posted Date: 2016-12-15

Last Posted Date: 2021-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 49

Registration Number: NCT02994433

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Intensive Cardiac Rehabilitation (ICR): Tolerability and Effectiveness

Conditions: Cardiac Disease

First Posted Date: 2016-12-08

Last Posted Date: 2023-12-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 500

Registration Number: NCT02987049

Steroid Nasal Irrigation for Flavor Evaluation and Detection Study

Not Applicable

Completed

Conditions: Olfactory Disorder

Interventions: Behavioral: Smell training

First Posted Date: 2016-12-07

Last Posted Date: 2022-11-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 51

Registration Number: NCT02985515

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI

Phase 2

Terminated

Conditions: Major Depressive Disorder
Traumatic Brain Injury

Interventions: Procedure: Active
Procedure: Sham

First Posted Date: 2016-12-02

Last Posted Date: 2018-03-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT02980484

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Early Phase 1

Withdrawn

Conditions: Mixed Glioma
Astrocytoma
Brainstem Glioma
Ependymoma
Oligodendroglioma
Optic Nerve Glioma

Interventions: Radiation: Radiation therapy
Drug: Temozolomide
Procedure: Stem cell collection
Procedure: Stem cell infusion

First Posted Date: 2016-11-29

Last Posted Date: 2017-02-20

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02976441

Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

Phase 4

Terminated

Conditions: Kidney Transplant Rejection
Gastrointestinal Disorder, Functional

Interventions: Drug: Mycophenolic Acid
Drug: Everolimus

First Posted Date: 2016-11-28

Last Posted Date: 2020-08-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1

Registration Number: NCT02974686

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Improving Adherence in Renal Dialysis Patients Through Electronic Interventions

Not Applicable

Completed

Conditions: Endstage Renal Disease

Interventions: Other: EpxDialysis

First Posted Date: 2016-11-21

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT02970201

Locations: 🇺🇸
Washington University School of Medicine - Barnes Jewish Hospital, Saint Louis, Missouri, United States

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

Phase 4

Completed

Conditions: Treatment Resistant Depression
Major Depressive Disorder
Treatment-Refractory Depression
Late Life Depression
Geriatric Depression

Interventions: Drug: Aripiprazole Augmentation
Drug: Switch to bupropion
Drug: Lithium Augmentation
Drug: Bupropion Augmentation
Drug: Switch to nortriptyline

First Posted Date: 2016-11-10

Last Posted Date: 2024-10-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 742

Registration Number: NCT02960763

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
🇺🇸
Washington University School of Medicine Healthy Mind Lab, Saint Louis, Missouri, United States
🇺🇸
UCLA Late-Life Mood, Stress, and Wellness Research Program, Los Angeles, California, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy